Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment

References

• Barlogie B, Corry PM, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum (II) and mitomycin C. Cancer Res 1980;40:1165–8
   PubMed Web of Science ®Google Scholar
• Herman TS, Teicher BA, Collins LS. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures. Cancer Res 1988;48:2342–7
   PubMed Web of Science ®Google Scholar
• Hall EJ. Radiobiology for the radiologist. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2000
   Google Scholar
• van Bree C, Rietbroek R, Schopman E, Kipp J, Bakker P. Local hyperthermia enhances the effect of cis-diamminedichloro-platinum(II) on nonirradiated and preirradiated rat solid tumors. Int J Radiation Oncology Biol Phys 1996;36:135,135–96
   PubMed Web of Science ®Google Scholar
• Bull JM. An update on the anticancer effects of a combination of chemotherapy and hyperthermia. Cancer Res 1984;44:S4853–6
   PubMed Web of Science ®Google Scholar
• Hahn GM. Metabolic aspects of the role of hyperthermia in mammalian cell inactivation and their possible relevance to cancer treatment. Cancer Res 1974;34:3117–23
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol 2002;43:33–56
   PubMed Web of Science ®Google Scholar
• Song CW, Park HJ, Lee CK, Griffin R. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005;21:761–7
   PubMed Web of Science ®Google Scholar
• Ausmus PL, Wilke AV, Frazier DL. Effects of hyperthermia on blood flow and cis-diamminedichloroplatinum(II) pharmacokinetics in mammary adenocarcinomas. Cancer Res 1992;52:4965–8
   PubMed Web of Science ®Google Scholar
• Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984;44:605–12
   PubMed Web of Science ®Google Scholar
• Fuertes M, Castilla J, Alonso C, Prez J. Cisplatin biochemical mechanism of action: From cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 2003;10:257–66
   PubMed Web of Science ®Google Scholar
• Gonzalez VM, Fuertes MA, Alonso C, Perez JM. Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 2001;59:657–63
   PubMed Web of Science ®Google Scholar
• Hartmann JT, Kollmannsberger C, Kanz L, Bokemeyer C. Platinum organ toxicity and possible prevention in patients with testicular cancer. Int J Cancer 1999;83:866–9
   PubMed Web of Science ®Google Scholar
• Sooriyaarachchi M, Narendran A, Gailer J. Comparative hydrolysis and plasma protein binding of cisplatin and carboplatin in human plasma in vitro. Metallomics 2011;3:49–55
   PubMed Web of Science ®Google Scholar
• Meyn RE, Corry PM, Fletcher SE, Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res 1980;40:1136–9
   PubMed Web of Science ®Google Scholar
• Hettinga J, Konings A, Kampinga H. Reduction of cellular cisplatin resistance by hyperthermia – A review. Int J Hyperthermia 1997;13:439–57
   PubMed Web of Science ®Google Scholar
• Van de Vaart P, Van der Vange N, Zoetmulder F, Van Goethem A, Van Tellingen O, ten Bokkel Huinink W, et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: Pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 1998;34:148–54
   PubMed Web of Science ®Google Scholar
• Wallner KE, DeGregorio MW, Li GC. Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res 1986;46:6242–5
   PubMed Web of Science ®Google Scholar
• Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med 2002;53:615–27
   PubMed Web of Science ®Google Scholar
• Taylor A, Krupskaya Y, Krämer K, Füssel S, Klingeler R, Büchner B, et al. Cisplatin-loaded carbon-encapsulated iron nanoparticles and their in vitro effects in magnetic fluid hyperthermia. Carbon 2010;48:2327–34
   Web of Science ®Google Scholar
• Kettering M, Zorn H, Bremer-Streck S, Oehring H, Zeisberger M, Bergemann C, et al. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys Med Biol 2009;54:5109–21
   PubMed Web of Science ®Google Scholar
• Lee JS, Rodriguez-Luccioni HL, Méndez J, Sood AK, Lpez-Berestein G, Rinaldi C, et al. Hyperthermia induced by magnetic nanoparticles improves the effectiveness of the anticancer drug cis-diamminedichloroplatinum. J Nanosci Nanotechnol 2011;11:4153–7
   PubMed Web of Science ®Google Scholar
• Babincov M, Altanerov V, Altaner C, Bergemann C, Babinec P. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans Nanobioscience 2008;7:15–19
   PubMed Web of Science ®Google Scholar
• Hoffman NA, Gollin FF, Clifton KH. Acquired radioresistance of transplanted mammary adenocarcinoma in inbred mice after serial irradiation. Radiology 1967;88:568–75
   PubMed Web of Science ®Google Scholar
• Cohn NK, Clifton KH. Aspects of the biology and radiation response of cloned C3H mouse mammary carcinoma cells in vitro and in vivo. Eur J Cancer 1971;7:505–14
   Web of Science ®Google Scholar
• Grüttner C, Müller K, Teller J, Westphal F, Foreman A, Ivkov R. Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. J Magn Magn Mater 2007;311:181–6
   Web of Science ®Google Scholar
• micromod Partikeltechnologie, Rostock, Germany. Functionalized Micro- and Nanoparticles, product details (accessed 2013). http://www.micromod.de/en/functionalized-micro-and-nanoparticles-1.html
   Google Scholar
• Fluxtrol Center for Induction Technology, Auburn Hills, MI. Ferrotron 559H, product details, 2010 (accessed 2013). http://fluxtrol.com/products/product-types/ferrotron-559h/
   Google Scholar
• Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003;19:267–94
   PubMed Web of Science ®Google Scholar